Related Experiment Videos
Intravenous imipenem prophylaxis in experimental endophthalmitis
Herminia Miño de Kaspar1, Michael Engelbert, Martin Thiel
1Department of Ophthalmology, Stanford University, School of Medicine, California, USA. hminokaspar@cs.com
Summary
Prophylactic intravenous imipenem significantly reduced inflammation and bacterial load in experimental Staphylococcus aureus endophthalmitis. This antibiotic strategy proved effective in preventing or mitigating severe eye infections caused by S. aureus.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Pharmacology
Background:
- Endophthalmitis is a severe intraocular infection often caused by bacteria.
- Staphylococcus aureus is a common pathogen implicated in endophthalmitis.
- Prophylactic antibiotic strategies are crucial in preventing post-infectious complications.
Purpose of the Study:
- To evaluate the efficacy of prophylactic intravenous imipenem in a rabbit model of Staphylococcus aureus endophthalmitis.
- To assess the impact of imipenem on ocular inflammation and bacterial presence.
Main Methods:
- New Zealand albino rabbits were inoculated intraocularly with varying doses (100, 1,000, or 10,000 CFU) of S. aureus.
- Experimental groups received intravenous imipenem at specific time points (8h prior, 30min prior, 8h post-inoculation).
- Ocular inflammation was assessed via slit-lamp examination and funduscopy; vitreous cultures and histological evaluations were performed.
Main Results:
- Imipenem prophylaxis significantly reduced clinical and histological inflammation across tested bacterial concentrations (P<0.001).
- Prophylactic imipenem led to significantly fewer positive vitreous cultures at lower S. aureus doses (100 and 1,000 CFU).
- No significant difference was observed between control and prophylactic groups at the highest bacterial dose (10,000 CFU).
Conclusions:
- Intravenous imipenem administered prophylactically can effectively prevent or substantially decrease the severity of experimental S. aureus endophthalmitis.
- The findings support the potential role of prophylactic imipenem in managing or preventing severe ocular infections.